Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About
  • Text only
  • |
  • Sign in
  • Search News & Events
  • Search University of Warwick
  • Search for people at Warwick
  • Search Warwick Blogs
  • Search past exam papers
  • Search video
  • More…

    News & Events

    • Press and Media
    • Press Releases
    • Expert Comment
    • Latest News
    • Events
    • Social Media
    University of Warwick

    Scientists report a potential new treatment to prevent strokes

    Professor Donald SingerScientists may have discovered a new way to prevent strokes in high risk patients, according to research from the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW).

    Work by a new research group, led by Professor Donald Singer, Professor of Therapeutics at Warwick Medical School and Professor Chris Imray from UHCW, has now been published in US journal Stroke.

    The group is using ultrasound scanning to look at patients with carotid artery disease, one of the major causes of stroke. Clots can form on diseased carotid arteries in the neck. Small parts of these clots can released to form microemboli, which can travel to block key brain arteries and lead to weakness, disturbed speech, loss of vision and other serious stroke syndromes. Standard anti-platelet drugs such as aspirin may not prevent the formation of harmful microemboli.

    The scanning process can be used to find patients at very high risk of stroke because microemboli have formed despite prior anti-platelet drugs. Using scanning, the team has found that tirofiban, another anti-platelet drug designed to inhibit the formation of blood clots, can suppress microemboli where previous treatment such as aspirin has been ineffective. In their study, tirofiban was more effective than other ‘rescue’ treatment.

    Professor Singer said: “These findings show that the choice of rescue medicine is very important when carotid patients develop microemboli despite previous treatment with powerful anti-platelet drugs such as aspirin. We now need to go on to further studies of anti-microemboli rescue treatments, to aim for the right balance between protection and risk for our patients.”

    Professor Imray said: “These findings show the importance of ultrasound testing for micro-emboli in carotid disease patients. These biomarkers of high stroke risk cannot be predicted just from assessing the severity of risk factors such as smoking history, cholesterol and blood pressure.”


    Notes to editors
    The paper is called ‘Registry Report on Kinetics of Rescue Antiplatelet Treatment to Abolish Cerebral Microemboli After Carotid Endarterectomy, ’ Mahmud Saedon, Donald R.J. Singer, Raymand Pang, Carl Tiivas, Charles E. Hutchinson. Stroke, ISSN: 0039-2499.

    A copy of the paper is available here http://stroke.ahajournals.org/content/early/2012/10/18/STROKEAHA.112.676338.full.pdf?ijkey=ncr7ulNxpDtRxxG&keytype=ref

    For more information contact Kelly Parkes-Harrison, Press and Communications Manager, University of Warwick, k.e.parkes@warwick.ac.uk, 02476 150868, 07824 540863.

     

     



    Related Links

    Professor Singer's Profile

    Warwick Medical School Website

    @WarwickMed on Twitter

    facebook twitter itunesu
    Quick links
    Experts Directory
    Telephone listings
    Communications Office
    Press and Media Relations
    Image Library
    University Profile

    Contact us: University of Warwick, Coventry CV4 7AL, UK Tel: +44(0)24 7652 3523 Fax: +44 (0)24 7646 1606

    Close this email form
    Page contact: Web Editor Last revised: Thu 22 Nov 2012
    • Sign in
    • |
    • Powered by Sitebuilder
    • |
    • © MMXIII
    • |
    • Terms
    • |
    • Privacy
    • |
    • Cookies
    • |
    • Accessibility